Ocular Complications of Leprosy in Yemen

Overview

Journal Sultan Qaboos Univ Med J

Specialty General Medicine

Date 2013 Jan 1

PMID 23275842

Citations 2

Authors

Raga A A Salem

Affiliations

Soon will be listed here.

Abstract

Objectives: This study was conducted to identify the main ocular- and vision-threatening complications of leprosy in Yemen.

Methods: This is a cross-sectional observational study which took place from February to July 2010. Leprosy patients attending the Skin and Venereal Diseases Hospital in the City of Light in Taiz, Yemen, who consented to participate in the study, were enrolled. Detailed demographic and medical histories were taken and clinical examination findings were recorded. A detailed eye examination, including visual acuity (VA), slit-lamp, and fundus examinations, was conducted on each patient by a qualified ophthalmologist.

Results: A total of 192 patients (180 male, 12 female, with a male to female ratio of 15:1) were included in the study. The majority of the patients (157; 81.8%) were over 40 years. Over two-thirds of the patients (129; 67.2%) had had leprosy for more than 20 years. Ocular complications were found in 97% of cases; 150 (39.1%) of the patients' eyes had at least one pathology. Eyelid involvement was the most common problem observed in 102 (26.5%) patients. Half of the eyes (192; 50%) had a VA of <6/60. The main cause of blindness among these patients was corneal opacity detected in 69 out of 192 patients (35.9%).

Conclusion: Ocular complications are frequent among leprosy patients in Yemen. They are true vision-threatening lesions. It is important to prevent these lesions through early diagnosis and adequate treatment.

Citing Articles

A rare cause of acquired esotropia: Leprosy.

Canleblebici M, Yildirim H, Balbaba M, Aydemir O Indian J Ophthalmol. 2022; 70(7):2752-2754.

PMID: 35791236 PMC: 9426059. DOI: 10.4103/ijo.IJO_3631_20.

The clinical & neurophysiological study of leprosy.

Cabalar M, Yayla V, Ulutas S, Senadim S, Oktar A Pak J Med Sci. 2014; 30(3):501-6.

PMID: 24948967 PMC: 4048494. DOI: 10.12669/pjms.303.5354.

References

Ffytche T . Cataract surgery in the management of the late complications of lepromatous leprosy in South Korea. Br J Ophthalmol. 1981; 65(4):243-8. PMC: 1039491. DOI: 10.1136/bjo.65.4.243. View

Hogeweg M, Keunen J . Prevention of blindness in leprosy and the role of the Vision 2020 Programme. Eye (Lond). 2005; 19(10):1099-105. DOI: 10.1038/sj.eye.6701984. View

Ibrahim M, Kordy M, Aiderous A, Bahnassy A . Leprosy in Saudi Arabia, 1986-89. Lepr Rev. 1990; 61(4):379-85. DOI: 10.5935/0305-7518.19900036. View

Job C . PATHOLOGY OF LEPROUS OSTEOMYELITIS. Int J Lepr. 1963; 31:26-33. View

Al-Kandari S, Pugh R . Leprosy in Kuwait: an epidemiological study of new cases. Ann Trop Med Parasitol. 1990; 84(5):513-22. DOI: 10.1080/00034983.1990.11812503. View

Hornblass A . Ocular leprosy in South Vietnam. Am J Ophthalmol. 1973; 75(3):478-80. DOI: 10.1016/0002-9394(73)91160-4. View

Nepal B, Shrestha U . Ocular findings in leprosy patients in Nepal in the era of multidrug therapy. Am J Ophthalmol. 2004; 137(5):888-92. DOI: 10.1016/j.ajo.2003.12.048. View

Mvogo C, Ellong A, Achu J, Nkeng P . Ocular complications of leprosy in Cameroon. Acta Ophthalmol Scand. 2001; 79(1):31-3. DOI: 10.1034/j.1600-0420.2001.079001031.x. View

Mpyet C, Solomon A . Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria. Br J Ophthalmol. 2005; 89(4):417-9. PMC: 1772607. DOI: 10.1136/bjo.2004.048777. View

10.

Bahr G, Chugh T, Behbehani K, Shaaban M, Al Shimali B, Siddiqui Z . Unexpected findings amongst the skin test responses to mycobacteria of BCG vaccinated Kuwaiti school children. Tubercle. 1987; 68(2):105-12. DOI: 10.1016/0041-3879(87)90025-0. View

11.

Monteiro L, Campos W, Orefice F, Grossi M . Study of ocular changes in leprosy patients. Indian J Lepr. 1998; 70(2):197-202. View

12.

HOLMES W . The eyes in leprosy. Trans Ophthalmol Soc U K (1962). 1961; 81:397-420. View

13.

FAWDRY A . Notes on leprosy in Aden. Lepr Rev. 1959; 30(2):114-7. DOI: 10.5935/0305-7518.19590018. View

14.

Thompson K, Allardice G, Babu G, Roberts H, Kerketta W, Kerketta A . Patterns of ocular morbidity and blindness in leprosy--a three centre study in Eastern India. Lepr Rev. 2006; 77(2):130-40. View

15.

Courtright P, Lewallen S, Tungpakorn N, Cho B, Lim Y, Lee H . Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol. 2001; 85(6):643-7. PMC: 1723998. DOI: 10.1136/bjo.85.6.643. View

16.

Al-Mutairi N, Al-Doukhi A, Ahmad M, El-Khelwany M, Al-Haddad A . Changing demography of leprosy: Kuwait needs to be vigilant. Int J Infect Dis. 2010; 14(10):e876-80. DOI: 10.1016/j.ijid.2010.07.001. View

17.

Lamba P, Kumar D . Ocular involvement from leprosy. Indian J Ophthalmol. 1984; 32(2):61-3. View

18.

Choyce D . Ocular leprosy, with reference to certain cases shown. Proc R Soc Med. 1955; 48(2):108-12. PMC: 1919016. View

19.

Al-Kubati A . Dermatologists combat leprosy in Yemen. Int J Dermatol. 1998; 36(12):920-2. DOI: 10.1046/j.1365-4362.1997.00244.x. View

20.

Malla O, Brandt F, Anten J . Ocular findings in leprosy patients in an institution in Nepal (Khokana). Br J Ophthalmol. 1981; 65(4):226-30. PMC: 1039488. DOI: 10.1136/bjo.65.4.226. View